Delisting for a public company could be quite negative, but I wonder if the ultimate goal is to sell Vascepa/Vazkepa to BP whether it matters. Yesterday Eli Lilly paid 2.5 billion for Scorpion Therapeutics, which is a private company.
I think being delisted is what denner wants. Retail will bail as shorts destroy the stock price and he can come in and buy it up dirt cheap. Lets be clear Denner only cares about Denner as that has become pretty obvious.
Market Data 
Markets 
AI
